|
TIBCO Spotfire is pleased to present this webcast, recorded on April 22, 2009. View this complimentary recording, moderated by TIBCO Spotfire's Michael O'Connell, and hear perspectives on clinical data analysis using Spotfire from implementations at Novartis, AstraZeneca and Roche. Our distinguished panel of speakers will cover a series of interesting topics including:
-
Exploratory Data Analysis in Preclinical and Clinical Safety
- Michael Merz, Novartis
-
Maximizing Safety in Clinical Pharmacology Unit Studies
- Ian Taylor and Paula Johansson, AstraZeneca
-
Use of Spotfire in Early/Exploratory Drug Development
- Michaela Jahn and Xavier Liogier D'ardhuy, Roche
Spotfire’s ability to enable informative instream monitoring of complex clinical data creates efficiencies in clinical trial analysis and decision-making. This drives a highly productive drug development culture across clinical development organizations, leading to shorter development cycles and fast, safe product approvals.
We welcome you view this informative session from a highly distinguished group of clinical data analysts.
|